Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Exposure to resveratrol triggers pharmacological correction of fatty acid utilization in human fatty acid oxidation-deficient fibroblasts.

Human molecular genetics - 15 May 2011

Bastin Jean, Lopes-Costa Alexandra, Djouadi Fatima

Abstract excerpt

Carnitine palmitoyl transferase 2 (CPT2) and very-long-chain Acyl-CoA dehydrogenase (VLCAD) deficiencies are among the most common inborn mitochondrial fatty acid β-oxidation (FAO) disorders. Despite advances in their clinical and molecular characterizations, few therapeutic approaches exist for these diseases. Resveratrol (RSV) is a natural polyphenol extensively studied for its potential health benefits....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acyl-CoA Dehydrogenase, Long-Chain
Share to AMP-Activated Protein Kinase Kinases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antioxidants

Share to Carnitine O-Palmitoyltransferase

Share to Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha

Share to Resveratrol

Share to Sirtuin 1

Share to Stilbenes

Source

Identifiers

PMID: 21378393
DOI: 10.1093/hmg/ddr089

Genes

CPT2
PGC
SIRT1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Exposure to resveratrol triggers pharmacological correction of fatty acid utilization in human fatty acid oxidation-deficient fibroblasts.PMID 21378393Read ↗

Resveratrol-Induced Changes in MicroRNA Expression in Primary Human Fibroblasts Harboring Carnitine-Palmitoyl Transferase-2 Gene Mutation, Leading to Fatty Acid Oxidation Deficiency.Semantic proximity Read ↗

Beneficial effects of resveratrol on respiratory chain defects in patients' fibroblasts involve estrogen receptor and estrogen-related receptor alpha signalingSemantic proximity Read ↗

Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha.Semantic proximity Read ↗

Resveratrol and MyopathySemantic proximity Read ↗

Cellular and molecular effects of resveratrol in health and diseaseSemantic proximity Read ↗

The Effect of Resveratrol on Mitochondrial Function in Myoblasts of Patients with the Common m.3243A>G Mutation.Semantic proximity Read ↗

The journey of resveratrol from yeast to humanSemantic proximity Read ↗

Salidroside Delays Cellular Senescence by Stimulating Mitochondrial Biogenesis Partly through a miR-22/SIRT-1 PathwaySemantic proximity Read ↗

Mitochondrial Genetic Disorders: Cell Signaling and Pharmacological TherapiesSemantic proximity Read ↗

Resveratrol and life extensionSemantic proximity Read ↗

The Effect of Resveratrol on a Cell Model of Human AgingSemantic proximity Read ↗

Caloric restriction, resveratrol and melatonin: Role of SIRT1 and implications for aging and related-diseasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.